Inhibitors of bruton's tyrosine kinase

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S237000

Reexamination Certificate

active

07902194

ABSTRACT:
This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-IV:wherein, variables R, X, Y1, Y2, Y2, Y3, Y4, n and m are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions comprising compounds of Formulae I-IV and at least one carrier, diluent or excipient.

REFERENCES:
patent: 2008/0153834 (2008-06-01), Blomgren et al.
patent: WO 2004/022562 (2004-03-01), None
patent: WO 2005/014599 (2005-02-01), None
patent: 2006099075 (2006-09-01), None
patent: 2006124731 (2006-11-01), None
patent: 2007021795 (2007-02-01), None
patent: 2007027528 (2007-03-01), None
patent: 2007027594 (2007-03-01), None
patent: 2007027729 (2007-03-01), None
patent: 2007136465 (2007-11-01), None
patent: 2008033854 (2008-03-01), None
patent: 2008033857 (2008-03-01), None
patent: 2008033858 (2008-03-01), None
patent: WO 2008/033854 (2008-03-01), None
patent: 2009039397 (2009-03-01), None
patent: 2009053269 (2009-04-01), None
patent: WO 2009/077334 (2009-06-01), None
Hunter, T.Cell(1987) 50:823-829.
Rastetter, et al.Annu Rev Med(2004) 55:477-503.
Khan et al.Immunity(1995) 3:283-299.
Ellmeier, et al.J. Exp. Med. (2000) 192:1611-1623.
Rosen, et al.New Eng. J. Med. (1995) 333:431.
Lindvall, et al.Immunol. Rev. (2005) 203:200-215.
Jansson and HolmdahlClin. Exp. Immunol. (1993) 94:459-465.
Pan, Z. et al.Chem. Med Chem. (2007) 2:58-61.
Iwaki, et al.J. Biol. Chem. (2005) 280:40261-40270.
Horwood, et al.J. Exp. Med. (2003) 197:1603-1611.
Islam and Smith,Immunol. Rev. (2000) 178:49-63.
Feldhahn, et al.J. Exp. Med. (2005) 201:1837-1852.
Vassilev, et al.J. Biol. Chem. (1998) 274, 1646-1656.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of bruton's tyrosine kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of bruton's tyrosine kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of bruton's tyrosine kinase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2720774

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.